Crop Life Science Past Earnings Performance
Past criteria checks 3/6
Crop Life Science has been growing earnings at an average annual rate of 64.8%, while the Chemicals industry saw earnings growing at 16.8% annually. Revenues have been growing at an average rate of 29.2% per year. Crop Life Science's return on equity is 11.8%, and it has net margins of 3.6%.
Key information
64.8%
Earnings growth rate
64.8%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 29.2% |
| Return on equity | 11.8% |
| Net Margin | 3.6% |
| Last Earnings Update | 28 Feb 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Crop Life Science makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 28 Feb 23 | 1,337 | 48 | 129 | 0 |
| 31 Mar 22 | 1,020 | 28 | 136 | 0 |
| 31 Mar 21 | 1,189 | 37 | 139 | 0 |
| 31 Mar 20 | 1,351 | 32 | 121 | 0 |
Quality Earnings: CLSL has high quality earnings.
Growing Profit Margin: CLSL's current net profit margins (3.6%) are higher than last year (2.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if CLSL's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare CLSL's past year earnings growth to its 5-year average.
Earnings vs Industry: CLSL earnings growth over the past year (64.8%) exceeded the Chemicals industry -4.7%.
Return on Equity
High ROE: CLSL's Return on Equity (11.8%) is considered low.